Economic burden of children hospitalized with respiratory syncytial virus infection in Spain, 2016–2019

This retrospective observational study aimed to quantify the costs associated with hospitalized respiratory syncytial virus (RSV) in children

Saved in:
Bibliographic Details
Published in:Vaccine 2025-01, Vol.43 (Pt 2), p.126512, Article 126512
Main Authors: Haeberer, M., López-Ibáñez de Aldecoa, A., Seabroke, S., Ramirez Agudelo, J.L., Mora, L., Sarabia, L., Meroc, E., Aponte-Torres, Z., Sato, R., Law, A.W.
Format: Article
Language:English
Subjects:
Adolescent
Age
Age groups
bronchiolitis
Bronchitis
Bronchopneumonia
Child
Child, Preschool
Children
Congenital diseases
Cost
cost estimates
Cost of Illness
Costs
Diagnosis related groups
DRGs
Economics
Fatalities
Female
Health Care Costs - statistics & numerical data
health services
Hospitalization
Hospitalization - economics
Hospitalization - statistics & numerical data
Hospitals
Humans
Immunization
Incidence
Infant
Infant, Newborn
Infants
Infections
Influenza
influenza vaccines
Influenza, Human - economics
Influenza, Human - epidemiology
Male
mixed infection
Monoclonal antibodies
Observational studies
Patient admissions
Pneumonia
premature birth
Respiratory syncytial virus
Respiratory Syncytial Virus Infections - economics
Respiratory Syncytial Virus Infections - epidemiology
Respiratory Syncytial Virus, Human
Retrospective Studies
Risk factors
risk ranking
Spain
Spain - epidemiology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This retrospective observational study aimed to quantify the costs associated with hospitalized respiratory syncytial virus (RSV) in children
ISSN:0264-410X
1873-2518
1873-2518
DOI:10.1016/j.vaccine.2024.126512